Wall Street Analysts Make Moves on Top Stocks

Wall Street analysts have been busy this week, making adjustments to their outlooks on several prominent companies. These changes, which include both upgrades and downgrades, provide insights into the current market sentiment and potential investment opportunities. Here’s a breakdown of the key moves:

Oracle Corporation (ORCL):

TD Cowen raised the price target for Oracle from $165 to $180, maintaining a Buy rating. This bullish outlook suggests that analysts expect Oracle to perform well in the future, potentially exceeding its current valuation.

Boot Barn Holdings, Inc. (BOOT):

BTIG boosted the price target for Boot Barn Holdings from $150 to $165, also maintaining a Buy rating. This move reflects confidence in the company’s growth prospects, particularly in the retail sector.

Terns Pharmaceuticals, Inc. (TERN):

JMP Securities raised the price target for Terns Pharmaceuticals from $15 to $20, maintaining a Market Outperform rating. This upgrade indicates a positive view on the company’s potential for future success in the pharmaceutical industry.

Johnson Controls International plc (JCI):

B of A Securities raised the price target for Johnson Controls from $76 to $80, upgrading the stock from Neutral to Buy. This shift in rating indicates a more optimistic outlook on the company’s future performance.

Rubrik, Inc. (RBRK):

BMO Capital cut the price target for Rubrik from $40 to $38, maintaining an Outperform rating. While still positive, this slight reduction suggests a more cautious approach to the company’s potential.

Costco Wholesale Corporation (COST):

Redburn Atlantic boosted the price target for Costco from $860 to $890, but downgraded the stock from Buy to Neutral. This decision indicates a belief that the company is currently fairly valued, despite its strong performance.

IDEAYA Biosciences, Inc. (IDYA):

Stifel raised the price target for IDEAYA Biosciences from $63 to $68, maintaining a Buy rating. This upgrade suggests strong confidence in the company’s growth potential in the biopharmaceutical sector.

Axon Enterprise, Inc. (AXON):

Baird increased the price target for Axon Enterprise from $360 to $400, maintaining an Outperform rating. This move reflects a positive view on the company’s future performance, particularly in the technology sector.

Equity Residential (EQR):

Deutsche Bank boosted the price target for Equity Residential from $62 to $83, upgrading the stock from Hold to Buy. This upgrade suggests a more optimistic outlook on the company’s future performance.

News Corporation (NWSA):

Loop Capital boosted the price target for News Corporation from $38 to $39, maintaining a Buy rating. This reflects confidence in the company’s continued growth and profitability.

These analyst ratings and price target adjustments offer valuable insights into the current market sentiment and potential investment opportunities. However, it’s important to remember that these are just opinions and should be considered alongside your own research and investment goals.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top